A phase II trial of first-line bevacizumab in combination with pemetrexed and carboplatin in advanced nonsquamous non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Skaff, Z. G.
Hageboutros, A.
Krieger, K.
Coakley, S.
Somer, R.
Stevenson, J.
机构：
[1] Univ Med & Dent New Jersey, Camden, NJ USA
[2] Penn Presbyterian Med Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19091
引用
收藏
页数：2
相关论文
共 50 条
  • [1] 65 plus: A randomized phase III trial of pemetrexed and bevacizumab versus pemetrexed, bevacizumab, and carboplatin as first-line treatment for elderly patients with advanced nonsquamous, non-small cell lung cancer (NSCLC).
    Schuette, Wolfgang
    Nagel, Sylke
    Schneider, Claus-Peter
    Engel-Riedel, Walburga
    Schumann, Christian
    Kohlhaeufl, Martin
    Serke, Monika
    Hoeffken, Gert
    Kortsik, Cornelius
    Reck, Martin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Nonsquamous Non-small Cell Lung Cancer
    Clement-Duchene, Christelle
    Krupitskaya, Yelena
    Ganjoo, Kristen
    Lavori, Philip
    McMillan, Alex
    Kumar, Atul
    Zhao, Gary
    Padda, Sukhmani
    Zhou, Lisa
    San Pedro-Salcedo, Melanie
    Colevas, A. Dimitrios
    Wakelee, Heather A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (11) : 1821 - 1825
  • [3] A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer
    Spigel, David R.
    Hainsworth, John D.
    Shipley, Dianna L.
    Ervin, Thomas J.
    Kohler, Peter C.
    Lubiner, Eric T.
    Peyton, James D.
    Waterhouse, David M.
    Burris, Howard A., III
    Greco, F. Anthony
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) : 196 - 202
  • [4] Phase II trial of bevacizumab plus pemetrexed and carboplatin in previously untreated advanced nonsquamous non-small cell lung cancer
    Dalsania, C. J.
    Hageboutros, A.
    Harris, E.
    Krieger, K.
    Vora, C.
    Stevenson, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer
    Rodrigues-Pereira, Jose
    Kim, Joo-Hang
    Magallanes, Manuel
    Lee, Dae Ho
    Wang, Jie
    Ganju, Vinod
    Martinez-Barrera, Luis
    Barraclough, Helen
    van Kooten, Maximiliano
    Orlando, Mauro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1907 - 1914
  • [6] Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer
    Patel, Jyoti D.
    Hensing, Thomas A.
    Rademaker, Alfred
    Hart, Eric M.
    Blum, Matthew G.
    Milton, Daniel T.
    Bonomi, Philip D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) : 3284 - 3289
  • [7] A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.
    Spigel, D. R.
    Greco, F. A.
    Shipley, D.
    Ervin, T. J.
    Lubiner, E. T.
    Peyton, J. D.
    Bames, E. K.
    Thompson, D. S.
    Burris, H. A., III
    Hainsworth, J. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)
    Patel, J. D.
    Hensing, T. A.
    Rademaker, F.
    Hart, E.
    Obasaju, C. K.
    Treat, J.
    Milton, D.
    Bonomi, P. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] PHASE I STUDY OF TISLELIZUMAB IN COMBINATION WITH BEVACIZUMAB AND PEMETREXED IN FIRST-LINE TREATMENT FOR ADVANCED ELDERLY NONSQUAMOUS NON-SMALL CELL LUNG CANCER: TRIAL IN PROGRESS
    Ren, Xiubao
    Liu, Liang
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A737 - A737
  • [10] Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial
    Gervais, Radj
    Robinet, Gilles
    Clement-Duchene, Christelle
    Denis, Fabrice
    El Kouri, Claude
    Martin, Philippe
    Chouaki, Nadia
    Bourayou, Nawel
    Morere, Jean-Francois
    [J]. LUNG CANCER, 2013, 80 (02) : 185 - 190
12345